title: Effects of structural analogues of apelin-12 in acute myocardial infarction in rats.
abstract: OBJECTIVE
  To examine cardioprotective effects of Ρ-terminal fragment of adipokine apelin-12 (A12), its novel structural analogue [MeArg(1), NLe(10)]-A12 (I), and [d-Ala(12)]-A12 (II), a putative antagonist of APJ receptor, employing in vivo model of ischemia/reperfusion (I/R) injury.
  
  
  METHODS
  Peptides were synthesized by the automatic solid phase method using Fmoc technology. Anesthetized open-chest male Wistar rats were subjected to left anterior descending (LAD) coronary artery occlusion and coronary reperfusion. Hemodynamic variables and electrocardiogram (ECG) were monitored throughout the experiment. Myocardial injury was assessed by infarct size (IS), activity of necrosis markers in plasma, and metabolic state of the area at risk (AAR).
  
  
  RESULTS
  Intravenous injection of A12, I, or II at the onset of reperfusion led to a transient reduction of the mean arterial pressure. A12 or I administration decreased the percent ratio of IS/AAR by 40% and 30%, respectively, compared with control animals which received saline. Both peptides improved preservation of high-energy phosphates, reduced lactate accumulation in the AAR, and lowered CK-MB and LDH activities in plasma at the end of reperfusion compared with these indices in control. Treatment with II did not significantly affect either the IS/AAR, % ratio, or activities of both markers of necrosis compared with control. The overall metabolic protection of the AAR in the treated groups increased in the following rank: II < A12 < I.
  
  
  CONCLUSIONS
  The structural analogue of apelin-12 [MeArg(1), NLe(10)]-A12 may be a promising basis to create a new drug for the treatment of acute coronary syndrome.
authors: Russian Cardiology Research-and-Production Complex, Institute of Experimental Cardiology, Moscow, Russian Federation.
authors: Oleg I
authors: OI
authors: Pisarenko
authors: Larisa I
authors: LI
authors: Serebryakova
authors: Irina M
authors: IM
authors: Studneva
authors: Yulia A
authors: YA
authors: Pelogeykina
authors: Olga V
authors: OV
authors: Tskitishvili
authors: Zhanna D
authors: ZD
authors: Bespalova
authors: Maria V
authors: MV
authors: Sidorova
authors: Andrei A
authors: AA
authors: Az'muko
authors: Denis N
authors: DN
authors: Khatri
authors: Maria E
authors: ME
authors: Pal'keeva
authors: Alexander S
authors: AS
authors: Molokoedov
keywords: Analogues of apelin-12; markers of necrosis; metabolism of area at risk; myocardial infarction
references: Cardiovasc Drugs Ther. 2007 Dec;21(6):409-14
references: 17924178
references: Pharmacol Rev. 2007 Dec;59(4):418-58
references: 18048761
references: Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E834-41
references: 15265762
references: Basic Res Cardiol. 2007 Nov;102(6):518-28
references: 17694254
references: J Phys Chem B. 2009 Jul 30;113(30):10465-71
references: 19708686
references: Mol Cell Biochem. 1997 Jan;166(1-2):85-94
references: 9046024
references: Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E59-67
references: 19861585
references: Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2308-15
references: 21378145
references: Nature. 2006 Dec 14;444(7121):847-53
references: 17167472
references: Regul Pept. 2012 Feb 10;174(1-3):71-8
references: 22209991
references: Am J Pathol. 1978 Jan;90(1):57-70
references: 619696
references: Bull Exp Biol Med. 2011 Nov;152(1):79-82
references: 22803046
references: Regul Pept. 2008 Feb 7;146(1-3):271-7
references: 18022257
references: Pharmacol Ther. 2005 Aug;107(2):198-211
references: 15907343
references: Cardiovasc Res. 2004 Feb 15;61(3):402-13
references: 14962472
references: Pharmacol Ther. 2011 Feb;129(2):206-19
references: 20920528
references: Chin Med J (Engl). 2009 Oct 5;122(19):2360-5
references: 20079140
references: Int J Mol Med. 2008 Oct;22(4):547-52
references: 18813863
references: J Biol Chem. 2002 Apr 26;277(17):14838-43
references: 11815627
references: Eur J Heart Fail. 2009 Jun;11(6):551-8
references: 19351633
references: Peptides. 2007 Oct;28(10):2023-9
references: 17719140
references: Bioorg Khim. 2012 Jan-Feb;38(1):40-51
references: 22792704
references: Peptides. 2009 Jun;30(6):1144-52
references: 19463748
references: Endocrinology. 2005 Jan;146(1):231-6
references: 15486224
references: Biochem Biophys Res Commun. 1998 Oct 20;251(2):471-6
references: 9792798
references: Circulation. 2010 Apr 27;121(16):1818-27
references: 20385929